Macquarie Group

Macquarie Group’s Allogene Therapeutics ALLO Stock Holding History

Macquarie Group’s Portfolio ALLO Stock Details ALLO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-146,779	Closed	-$182K	–	874
2025 Q3	$182K	Hold	146,779	–	–	﹤0.01%	1495
2025 Q2	$166K	Hold	146,779	–	–	﹤0.01%	1549
2025 Q1	$214K	Hold	146,779	–	–	﹤0.01%	1531
2024 Q4	$313K	Hold	146,779	–	–	﹤0.01%	1479
2024 Q3	$411K	Hold	146,779	–	–	﹤0.01%	1497
2024 Q2	$342K	Hold	146,779	–	–	﹤0.01%	1513
2024 Q1	$656K	Hold	146,779	–	–	﹤0.01%	1422
2023 Q4	$471K	Hold	146,779	–	–	﹤0.01%	1479
2023 Q3	$465K	Hold	146,779	–	–	﹤0.01%	1448
2023 Q2	$729K	Hold	146,779	–	–	﹤0.01%	1406
2023 Q1	$725K	Hold	146,779	–	–	﹤0.01%	1418
2022 Q4	$923K	Sell	146,779 -593	-0.4%	-$5.49K	﹤0.01%	1436
2022 Q3	$1.6M	Sell	147,372 -1,097	-0.7%	-$14.9K	﹤0.01%	1299
2022 Q2	$1.69M	Hold	148,469	–	–	﹤0.01%	1352
2022 Q1	$1.35K	Hold	148,469	–	–	﹤0.01%	1472
2021 Q4	$2.21M	Buy	148,469 +140	+0.1%	+$2.47K	﹤0.01%	1347
2021 Q3	$3.81M	Hold	148,329	–	–	﹤0.01%	1182
2021 Q2	$3.87M	Hold	148,329	–	–	﹤0.01%	1209
2021 Q1	$5.24M	Sell	148,329 -454	-0.3%	-$15.3K	0.01%	897
2020 Q4	$3.76M	Hold	148,783	–	–	0.01%	933
2020 Q3	$5.61M	Hold	148,783	–	–	0.01%	798
2020 Q2	$6.37M	Buy	148,783 +2,004	+1%	+$72.5K	0.01%	741
2020 Q1	$2.85M	Hold	146,779	–	–	0.01%	841
2019 Q4	$3.81M	Hold	146,779	–	–	0.01%	873
2019 Q3	$4M	Hold	146,779	–	–	0.01%	820
2019 Q2	$3.94M	Hold	146,779	–	–	0.01%	837
2019 Q1	$4.24M	Hold	146,779	–	–	0.01%	819
2018 Q4	$3.95M	Buy	+146,779	New	+$3.9M	0.01%	809

Other funds holding ALLO

Pfizer New York $239M AUM 232.47% 1-Year Est. Return

TPG GP A Fort Worth, Texas $3.68B AUM 14.99% 1-Year Est. Return

BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return

Citadel Advisors

Citadel Advisors Miami, Florida $141B AUM 30.34% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Primecap Management

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Patient Square Capital Menlo Park, California $564M AUM 261.3% 1-Year Est. Return

Geode Capital Management

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return

Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return